Literature DB >> 27108886

Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples.

Elisa Giorgio1, Andrea Ciolfi2,3, Elisa Biamino4, Viviana Caputo5, Eleonora Di Gregorio6, Elga Fabia Belligni4, Alessandro Calcia1, Elena Gaidolfi7, Alessandro Bruselles8, Cecilia Mancini1, Simona Cavalieri6, Cristina Molinatto4, Margherita Cirillo Silengo4, Giovanni Battista Ferrero4, Marco Tartaglia2, Alfredo Brusco1,6.   

Abstract

Whole exome sequencing (WES) is a powerful tool to identify clinically undefined forms of intellectual disability/developmental delay (ID/DD), especially in consanguineous families. Here we report the genetic definition of two sporadic cases, with syndromic ID/DD for whom array-Comparative Genomic Hybridization (aCGH) identified a de novo copy number variant (CNV) of uncertain significance. The phenotypes included microcephaly with brachycephaly and a distinctive facies in one proband, and hypotonia in the legs and mild ataxia in the other. WES allowed identification of a functionally relevant homozygous variant affecting a known disease gene for rare syndromic ID/DD in each proband, that is, c.1423C>T (p.Arg377*) in the Trafficking Protein Particle Complex 9 (TRAPPC9), and c.154T>C (p.Cys52Arg) in the Very Low Density Lipoprotein Receptor (VLDLR). Four mutations affecting TRAPPC9 have been previously reported, and the present finding further depicts this syndromic form of ID, which includes microcephaly with brachycephaly, corpus callosum hypoplasia, facial dysmorphism, and overweight. VLDLR-associated cerebellar hypoplasia (VLDLR-CH) is characterized by non-progressive congenital ataxia and moderate-to-profound intellectual disability. The c.154T>C (p.Cys52Arg) mutation was associated with a very mild form of ataxia, mild intellectual disability, and cerebellar hypoplasia without cortical gyri simplification. In conclusion, we report two novel cases with rare causes of autosomal recessive ID, which document how interpreting de novo array-CGH variants represents a challenge in consanguineous families; as such, clinical WES should be considered in diagnostic testing.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  TRAPPC9; VLDRL; de novo CNV; intellectual disability; whole exome sequencing

Mesh:

Substances:

Year:  2016        PMID: 27108886     DOI: 10.1002/ajmg.a.37649

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  12 in total

1.  The role of CNVs in the etiology of rare autosomal recessive disorders: the example of TRAPPC9-associated intellectual disability.

Authors:  Jérémie Mortreux; Tiffany Busa; Dominique P Germain; Gwenaël Nadeau; Jacques Puechberty; Christine Coubes; Vincent Gatinois; Pierre Cacciagli; Yannis Duffourd; Jean-Marc Pinard; Hélène Tevissen; Laurent Villard; Damien Sanlaville; Nicole Philip; Chantal Missirian
Journal:  Eur J Hum Genet       Date:  2017-11-29       Impact factor: 4.246

Review 2.  Array comparative genomic hybridization and genomic sequencing in the diagnostics of the causes of congenital anomalies.

Authors:  Krzysztof Szczałuba; Urszula Demkow
Journal:  J Appl Genet       Date:  2016-11-18       Impact factor: 3.240

3.  Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability.

Authors:  Yonghong Li; Lori A Anderson; Edward I Ginns; James J Devlin
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

4.  Biallelic intragenic duplication in ADGRB3 (BAI3) gene associated with intellectual disability, cerebellar atrophy, and behavioral disorder.

Authors:  Carmela Scuderi; Lucia Saccuzzo; Mirella Vinci; Lucia Castiglia; Ornella Galesi; Michele Salemi; Teresa Mattina; Eugenia Borgione; Santina Città; Corrado Romano; Marco Fichera
Journal:  Eur J Hum Genet       Date:  2019-01-18       Impact factor: 4.246

5.  Distinct Autism Spectrum Disorder Phenotype and Hand-Flapping Stereotypes: Two Siblings with Novel Homozygous Mutation in TRAPPC9 Gene and Literature Review.

Authors:  Hilmi Bolat; Gül Ünsel-Bolat; Hatice Derin; Aşkın Şen; Serdar Ceylaner
Journal:  Mol Syndromol       Date:  2022-03-09

6.  Rare copy number variations affecting the synaptic gene DMXL2 in neurodevelopmental disorders.

Authors:  Gregory Costain; Susan Walker; Bob Argiropoulos; Danielle A Baribeau; Anne S Bassett; Erik Boot; Koen Devriendt; Barbara Kellam; Christian R Marshall; Aparna Prasad; Moises A Serrano; D James Stavropoulos; Hope Twede; Joris R Vermeesch; Jacob A S Vorstman; Stephen W Scherer
Journal:  J Neurodev Disord       Date:  2019-02-07       Impact factor: 4.025

7.  Novel Compound Heterozygous Mutations in the TRAPPC9 Gene in Two Siblings With Autism and Intellectual Disability.

Authors:  Areerat Hnoonual; Potchanapond Graidist; Supika Kritsaneepaiboon; Pornprot Limprasert
Journal:  Front Genet       Date:  2019-02-11       Impact factor: 4.599

8.  The clinical benefit of array-based comparative genomic hybridization for detection of copy number variants in Czech children with intellectual disability and developmental delay.

Authors:  Marketa Wayhelova; Jan Smetana; Vladimira Vallova; Eva Hladilkova; Hana Filkova; Marta Hanakova; Marcela Vilemova; Petra Nikolova; Barbora Gromesova; Renata Gaillyova; Petr Kuglik
Journal:  BMC Med Genomics       Date:  2019-07-23       Impact factor: 3.063

9.  Profound intellectual disability caused by homozygous TRAPPC9 pathogenic variant in a man from Malta.

Authors:  Katelynn M Wilton; Lauren B Gunderson; Linda Hasadsri; Christopher P Wood; Lisa A Schimmenti
Journal:  Mol Genet Genomic Med       Date:  2020-03-11       Impact factor: 2.183

Review 10.  Emerging role of NIK/IKK2-binding protein (NIBP)/trafficking protein particle complex 9 (TRAPPC9) in nervous system diseases.

Authors:  Brittany Bodnar; Arianna DeGruttola; Yuanjun Zhu; Yuan Lin; Yonggang Zhang; Xianming Mo; Wenhui Hu
Journal:  Transl Res       Date:  2020-05-17       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.